Medication risk analysis company MDI Health raises $20M

Healthcare analytics company MDI Health scored $20 million in Series A funding, bringing the company's total funding to $26 million. Intel Capital led the round with participation from Maverick Ventures Israel alongside existing investors Fresh.Fund, Arc Impact, Hanaco Ventures, Jumpspeed Ventures, former Optum senior vice president Richard Montwill, Welltech Ventures and Basad Ventures. Yoni Greifman, Intel Capital's investment director, will join MDI's board of directors. Israel-based MDI offers an AI-enabled tool that provides medication risk analysis based on a patient's medical records with the aim of preventing adverse drug reactions. The funds will help the company scale its U.S. and Israeli research and development teams.